Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Third Edition contains chapters discussing the unique requirements for the universal critical quality attributes, as well as the specific tests required to characterize and control different types of products, ranging in complexity from small molecules in immediate release oral dosage forms to complex products such as drug-antibody conjugates and mRNA-based products. This substantially expanded revision of the second edition will serve as practical comprehensive reference for scientists, managers, educators, and consultants involved in the development and regulation of pharmaceutical products.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Dr. Christopher Riley is the President of Riley and Rabel Consulting Services. He received a bachelor’s degree in Pharmacy (1977) and PhD degree in Pharmaceutical Chemistry (1980) from the University of Bath, UK. He taught Pharmaceutical Chemistry, at the Universities of Florida (1983-6) and the University of Kansas (1986-94), and was a Vice President at DuPont Merck (1994-2001) and ALZA (a division of J&J) (2001-7). He has coauthored more than 140 book chapters and papers in peer-reviewed journals, as well as 5 books. He has extensive experience in CMC regulatory affairs and the development of all types of dosage forms.
Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a fully comprehensive reference on specification setting for pharmaceuticals. The revisions and increased scope of this edition reflect changes in the regional and international regulations and guidelines, which have resulted in or have been driven by changes in approaches to the specification of new drug substances and new drug products.
Some of the notable changes are the increased emphasis on the importance of the analytical target profile, analytical procedure life-cycle management, and continuous method improvement. New topics include regional differences in quality requirements compared with those recommended by the International Council on Harmonization (ICH) (notably revision of the validation guideline, Q2, and publication of a new guideline Q14 Analytical Procedure Development). New chapters include pharmacopeial recommendations, the analytical content of application for clinical trials, marketing authorization applications, an additional chapter on solid-state methods, and chapters on specific dosage forms containing orally administered products, topicals, transdermals, inhalation products, ophthalmics, parenterals, nanoparticles, biosimilars, antibodies and drug–antibody conjugates, oligonucleotides, vaccines, and connected drug–devices combination products. The bioanalysis chapter has been supplemented by a separate chapter on the bioanalysis of nucleotides.
This substantially expanded revision of the 2nd edition will serve as a practical comprehensive reference for scientists, managers, educators, and consultants involved in the development and regulation of pharmaceutical products.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
Condizione: new. Questo è un articolo print on demand. Codice articolo UHEN9HVICG
Quantità: Più di 20 disponibili
Da: Majestic Books, Hounslow, Regno Unito
Condizione: New. Codice articolo 397577419
Quantità: 3 disponibili
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. 3rd edition NO-PA16APR2015-KAP. Codice articolo 26398799636
Quantità: 3 disponibili
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New. Codice articolo 46752378-n
Quantità: 1 disponibili
Da: Revaluation Books, Exeter, Regno Unito
Paperback. Condizione: Brand New. 3rd edition. 894 pages. 11.00x8.75x1.50 inches. In Stock. This item is printed on demand. Codice articolo __0443134669
Quantità: 2 disponibili
Da: Biblios, Frankfurt am main, HESSE, Germania
Condizione: New. Codice articolo 18398799646
Quantità: 3 disponibili
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition. Codice articolo 46752378
Quantità: 1 disponibili
Da: Ria Christie Collections, Uxbridge, Regno Unito
Condizione: New. In. Codice articolo ria9780443134661_new
Quantità: Più di 20 disponibili
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Condizione: New. Codice articolo 46752378-n
Quantità: Più di 20 disponibili
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Condizione: As New. Unread book in perfect condition. Codice articolo 46752378
Quantità: Più di 20 disponibili